Rapid Resolution of Symptoms with Moxifloxacin Therapy in 7223 Patients with Acute Exacerbation of Chronic Bronchitis
- 1 January 2002
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 22 (10) , 641-651
- https://doi.org/10.2165/00044011-200222100-00001
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Apparent plateau in β-lactamase production among clinical isolates of Haemophilus influenzae and Moraxella catarrhalis in the United States: results from the LIBRA Surveillance initiativeInternational Journal of Antimicrobial Agents, 2002
- A Critical Review of the FluoroquinolonesDrugs, 2002
- A Multinational, Multicentre, Non-Blinded, Randomized Study of Moxifloxacin Oral Tablets Compared with Co-Amoxiclav Oral Tablets in the Treatment of Acute Exacerbation of Chronic BronchitisJournal of International Medical Research, 2001
- Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in the United States during 1999–2000, Including a Comparison of Resistance Rates since 1994–1995Antimicrobial Agents and Chemotherapy, 2001
- Bacterial Infection in Chronic Obstructive Pulmonary Disease in 2000: a State-of-the-Art ReviewClinical Microbiology Reviews, 2001
- Need for Annual Surveillance of Antimicrobial Resistance in Streptococcus pneumoniae in the United States: 2-Year Longitudinal AnalysisAntimicrobial Agents and Chemotherapy, 2001
- Antimicrobial Resistance of Streptococcus pneumoniae Recovered from Outpatients with Respiratory Tract Infections in Germany from 1998 to 1999: Results of a National Surveillance StudyJournal of Clinical Microbiology, 2001
- The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitisRespiratory Medicine, 2000
- BAY 12-8039, a novel fluoroquinoloneDiagnostic Microbiology and Infectious Disease, 1998
- Comparison of the antibacterial activities of the quinolones Bay 12- 8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin [published erratum appears in J Antimicrob Chemother 1998 Jun;41(6):672]Journal of Antimicrobial Chemotherapy, 1997